Panelists discuss how accurate and early diagnosis remains one of the most difficult challenges in schizophrenia care. Many ...
Explore how AI is revolutionizing psychology education, diagnosis, and treatment, addressing mental health challenges and ...
A new imagery-focused therapy called iMAPS may help people with psychosis gain control over disturbing mental images that ...
Data from the SERENITY At-Home Phase 3 trial were presented on November 7 at the 2025 Neuroscience Education Institute Fall Congress by Dr. Leslie Citrome.
Teva Pharmaceuticals has announced new real-world data showing that AUSTEDO (deutetrabenazine) tablets and AUSTEDO XR ...
Researchers found that adolescents treated with the antibiotic doxycycline were ~30% less likely to develop schizophrenia as ...
Even with Inflation Reduction Act (IRA)-related pressure looming for its top product, Teva Pharmaceuticals is continuing to ...
TipRanks on MSN
BioXcel Presents Phase 3 Study on BXCL501
Bioxcel Therapeutics ( ($BTAI) ) has provided an update. On November 10, 2025, BioXcel Therapeutics announced the presentation of their Phase 3 ...
In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their ...
The invisible friends Cat Price talked about in childhood were chalked up to an active imagination, and her adolescent angst and hostility got interpreted as teenage rebellion. When, as a high school ...
In this diverse cohort of patients with first-time psychotic spectrum disorders (PSDs), 45.7% were diagnosed in outpatient psychiatry clinics, and 42.0% were diagnosed in the emergency department (ED) ...
AI transforms healthcare by enhancing disease detection, patient care and hospital efficiency but requires careful implementation to ensure equity and effectiveness. Managed Healthcare Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback